Jackson Creek Investment Advisors LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 221 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 12.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
Jackson Creek Investment Advisors LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$764
-50.3%
16,620
-37.9%
0.32%
-47.5%
Q2 2023$1,538
+58.6%
26,758
+3.4%
0.62%
+51.1%
Q1 2023$970
-99.9%
25,877
-6.2%
0.41%
+12.1%
Q3 2022$775,000
-28.1%
27,577
-4.4%
0.36%
-16.7%
Q2 2022$1,078,000
-39.7%
28,837
-42.1%
0.44%
-33.2%
Q1 2022$1,788,000
+160.6%
49,814
+36.1%
0.65%
+110.0%
Q3 2020$686,00036,5900.31%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
FRIESS ASSOCIATES LLC 97,760$3,401,0005.68%
Nantahala Capital Management 1,000,000$34,790,0001.74%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 341,294$11,874,0001.52%
Portolan Capital Management 274,889$9,563,0000.96%
Quantedge Capital Pte Ltd 121,500$4,227,0000.85%
SHAKER INVESTMENTS LLC/OH 37,117$1,291,0000.82%
GLOBEFLEX CAPITAL L P 72,253$2,514,0000.61%
EAM Investors, LLC 68,855$2,395,0000.58%
Hillsdale Investment Management Inc. 197,738$6,879,0000.55%
Capital Impact Advisors, LLC 13,835$481,0000.44%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders